Download PDF
Clin Colon Rectal Surg 2002; 15(1): 063-070
DOI: 10.1055/s-2002-23569
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Multimodality Management of Recurrent Rectal Cancer

Claudio Belluco, Enrico Melega, Enzo Mammano, Salvatore Pucciarelli, Donato Nitti, Mario Lise
  • Department of Oncological and Surgical Sciences, University of Padova, Italy
Further Information

Publication History

Publication Date:
03 April 2002 (online)

Also available at
    Permissions and Reprints

ABSTRACT

The treatment of recurrent rectal cancer is a major challenge for surgeons, radiotherapists, and medical oncologists. In recent years, encouraging results have been reported with multimodality treatment. The goal of the present article is to outline strategies for the diagnosis and treatment of recurrent rectal cancer, based on data reported in the literature and our own experience. Following histologic confirmation, the pattern of recurrent disease and resectability are evaluated by a thorough preoperative diagnostic workup that includes clinical assessment, endoscopy, and imaging studies. Surgical treatment, tailored according to the pattern of pelvic recurrence, aims to achieve complete disease removal. However, when curative resection is infeasible, chemotherapy and preoperative or intraoperative radiotherapy are utilized in order to improve resectability rate and survival. A variety of different approaches have been proposed for the palliation of symptoms in patients with advanced local recurrent disease not amenable to multimodality treatment.

KEYWORD

Recurrent rectal cancer - multimodality treatment - surgery - radiotherapy - chemotherapy

REFERENCES

  • 1 Pahlman L, Glimelius B. The value of adjuvant radio(chemo)therapy for rectal cancer.  Eur J Cancer . 1995;  31 1347-1350
    CrossrefPubMedGoogle Scholar
  • 2 Rao A R, Kagan A R, Chan P M. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon.  Cancer . 1981;  48 1492-1495
    PubMedGoogle Scholar
  • 3 Abulafi A M, Williams N S. Local recurrence of colorectal cancer: the problem, mechanism, management and adjuvant therapy.  Br J Surg . 1994;  81 7-19
    PubMedGoogle Scholar
  • 4 Michelassi F, Vannucci L, Ayala J J. Local recurrence after curative colorectal adenocarcinoma.  Surgery . 1990;  108 787-793
    PubMedGoogle Scholar
  • 5 Pilipshen S J, Heilweil M, Quan S H. Patterns of pelvic recurrence following definitive resections of rectal cancer.  Cancer . 1984;  53 1354-1362
    CrossrefPubMedGoogle Scholar
  • 6 Miller A R, Cantor S B, Peoples G E. Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer.  Dis Colon Rectum . 2000;  43 1695-1701
    PubMedGoogle Scholar
  • 7 Salo J C, Paty P B, Guillem J. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience.  Ann Surg Oncol . 1999;  6 171-177
    CrossrefPubMedGoogle Scholar
  • 8 Mohiuddin M, Hayne M, Regine W F. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.  Int J Radiat Oncol Biol Phys . 2000;  48 1075-1080
    CrossrefPubMedGoogle Scholar
  • 9 Harrison L B, Minsk B D, Enker W E. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.  Int J Radiat Oncol Biol Phys . 1998;  42 325-330
    CrossrefPubMedGoogle Scholar
  • 10 Vanhoefer U, Harstrick A, Achterrath W. Irinotecan in the treatment of colorectal cancer. Clinical overview.  J Clin Oncol . Mar 1;  19 1501-1518
    PubMedGoogle Scholar
  • 11 Zalcberg J R, Cunningham D, Van Cutsem E. Tomudex (ZD 1694), a novel thymidylate syntase inhibitor has substantial activity in the treatment of patients with advanced colorectal cancer.  J Clin Oncol . 1996;  14 716-721
    PubMedGoogle Scholar
  • 12 Pelley E J. Oxaliplatin: a new agent for colorectal cancer.  Curr Oncol Rep . 2001;  3 147-155
    PubMedGoogle Scholar
  • 13 Safi F, Link K H, Beger H G. Is follow-up of colorectal cancer patients worthwhile?.  Dis Colon Rectum . 1993;  36 636-644
    PubMedGoogle Scholar
  • 14 Schiessel R, Wunderlich M, Herbst F. Local recurrence of colorectal cancer: effect of early detection and aggressive surgery.  Br J Surg . 1986;  73 342-344
    PubMedGoogle Scholar
  • 15 Guillem J G, Ruo L. Strategies in operative therapy for locally recurrent rectal cancer.  Semin Colon Rectal Surg . 1998;  9 259-268
    PubMedGoogle Scholar
  • 16 Pema P J, Bennett W F, Bova J G. CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma.  J Comput Assist Tomogr . 1994;  18 256-261
    PubMedGoogle Scholar
  • 17 Balzarini L, Ceglia E, D'Ippolito G. Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis?.  Gastrointest Radiol . 1990;  15 338-342
    CrossrefPubMedGoogle Scholar
  • 18 Falk P M, Gupta N C, Thorson A G. Positron emission tomography for preoperative staging of colorectal carcinoma.  Dis Colon Rectum . 1994;  37 153-156
    PubMedGoogle Scholar
  • 19 Beets G, Penninckx F, Schiepers C. Clinical value of whole-body positron emission tomography with [18F] fluoro-deoxyglucose in recurrent colorectal cancer.  Br J Surg . 1994;  81 1666-1670
    CrossrefPubMedGoogle Scholar
  • 20 Schiepers C, Penninckx F, De Vadder N. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging.  Eur J Surg Oncol . 1995;  21 517-522
    CrossrefPubMedGoogle Scholar
  • 21 Lai D T, Fulham M, Staphen M S. The role of whole-body positron emission tomography with [18F] fluoro-deoxyglucose in identifying operable colorectal cancer metastases to the liver.  Arch Surg . 1996;  131 703-707
    PubMedGoogle Scholar
  • 22 Haberkorn U, Strauss L G, Dimitrakopoulou A. PET studies of fluoro-deoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.  J Nucl Med . 1991;  32 1485-1490
    PubMedGoogle Scholar
  • 23 Jarv V, Blomqvist L, Holm T. Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma.  Acta Radiol . 2000;  41 629-633
    CrossrefPubMedGoogle Scholar
  • 24 Scneebaum S, Papo J, Graif M. Radioimmunoguided surgery benefits for recurrent colorectal cancer.  Ann Surg Oncol . 1997;  4 369-370
    PubMedGoogle Scholar
  • 25 Bertsch D J, Burak Jr E W, Young D C. Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer.  Surgery . 1995;  118 634-638
    PubMedGoogle Scholar
  • 26 Yeung R S, Moffat F L, Falk R E. Pelvic exenteration for recurrent colorectal carcinoma: a review.  Cancer Invest . 1994;  12 176-188
    PubMedGoogle Scholar
  • 27 Wiggers T, de Vries R M, Veeze-Kupyers B. Surgery for local recurrence of rectal carcinoma.  Dis Colon Rectum . 1996;  39 323-328
    PubMedGoogle Scholar
  • 28 Lopez-Kostner F, Fazio V W, Vignali A. Locally recurrent rectal cancer. Predictors and success of salvage surgery.  Dis Colon Rectum . 2001;  44 173-178
    CrossrefPubMedGoogle Scholar
  • 29 Hafner G H, Herrera L, Petrelli N J. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma.  Ann Surg . 1992;  215 63-67
    PubMedGoogle Scholar
  • 30 Suzuki K, Dozois R R, Devine R M. Curative reoperations for locally recurrent rectal cancer.  Dis Colon Rectum . 1996;  39 730-736
    CrossrefPubMedGoogle Scholar
  • 31 Mannaerts G HH, Rutten H JT, Matijn H. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer.  Dis Colon Rectum . 2001;  44 806-814
    PubMedGoogle Scholar
  • 32 Huguier M, Houry S. Treatment of local recurrence of rectal cancer.  Am J Surg . 1998;  175 288-292
    CrossrefPubMedGoogle Scholar
  • 33 Schneebaum S, Arnold M W, Young D. Role of carcinoembryonic antigen in predicting resectability of recurrent colorectal cancer.  Dis Colon Rectum . 1993;  36 810-815
    PubMedGoogle Scholar
  • 34 Cohen A M, Minsky B D. Aggressive surgical management of locally advanced primary and recurrent rectal cancer.  Dis Colon Rectum . 1990;  33 432-438
    PubMedGoogle Scholar
  • 35 Delpero J R, Pol B, Le Treut P Y. Surgical resection for locally recurrent colorectal adenocarcinoma.  Br J Surg . 1998;  85 372-376
    CrossrefPubMedGoogle Scholar
  • 36 Zacherl J, Schiessel R, Windhager R. Abdominosacral resection of recurrent rectal cancer in the sacrum.  Dis Colon Rectum . 1999;  42 1035-1040
    PubMedGoogle Scholar
  • 37 Wanebo H J, Koness R J, Vezeridis M P. Pelvic resection of recurrent rectal cancer.  Ann Surg . 1994;  220 586-595
    PubMedGoogle Scholar
  • 38 Brophy P F, Hoffman J P, Eisenberg B L. The role of pallitative pelvic exenteration.  Am J Surg . 1994;  167 386-390
    CrossrefPubMedGoogle Scholar
  • 39 Gagliardi G, Hawley P R, Hershman M J, Arnott S J. Prognostic factors in surgery for local recurrence of rectal cancer.  Brit J Surg . 1995;  82 1401-1405
    PubMedGoogle Scholar
  • 40 Ogunbiyi O A, McKenna K, Birnbaum E H. Aggressive surgical management of recurrent rectal cancer: is it worthwhile?.  Dis Colon Rectum . 1997;  40 150-155
    CrossrefPubMedGoogle Scholar
  • 41 Martin E W, Carey L C. Second-look surgery for colorectal cancer.  Ann Surg . 1991;  214 321-327
    PubMedGoogle Scholar
  • 42 Lasser P, Doidy L, Elias D. Total pelvic exenteration and rectal cancer. Apropos of 20 cases.  Chirurgie . 1999;  124 252-257
    CrossrefPubMedGoogle Scholar
  • 43 Lise M, Melega E, Pucciarelli S. Surgery for local recurrence from rectal cancer. 52nd Cancer Symposium, Orlando,Abstracts 1997 : 97
    Google Scholar
  • 44 Mohiuddin M, Marks G M, Lingareddy V, Marks J. Curative surgical resection following reirradiation for recurrent rectal cancer.  Int J Radiat Oncol Biol Phys . 1997;  39 643-649
    CrossrefPubMedGoogle Scholar
  • 45 Hu Kennet S, Harrison L B. Results and complications of surgery combined with intraoperative radiation therapy for the treatment of locally advanced or recurrent cancer in the pelvis.  Semin Surg Oncol . 2000;  18 269-278
    CrossrefPubMedGoogle Scholar
  • 46 Gunderson L L, Dozois R R. Intraoperative irradiation for locally advanced colorectal carcinomas.  Perspect Colon Rectal Surg . 1992;  5 1-24
    PubMedGoogle Scholar
  • 47 Harrison L B, Enker W E, Anderson L. High dose rate intraoperative radiation therapy for colorectal cancer.  Oncology . 1995;  9(7) 679-683
    PubMedGoogle Scholar
  • 48 Harrison L B, Enker W E, Anderson L. High dose rate intraoperative radiation therapy for colorectal cancer.  Oncology . 1995;  9(8) 737-741
    PubMedGoogle Scholar
  • 49 Mannaerts G HH, Martijn H, Crommelin M A. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma.  Int J Radiat Oncol Biol Phys . 1999;  45 297-308
    PubMedGoogle Scholar
  • 50 Hashiguchi Y, Sekine T, Sakamoto H. Intraoperative irradiation after surgery for locally recurrent rectal cancer.  Dis Colon Rectum . 1999;  42 886-895
    PubMedGoogle Scholar
  • 51 Lowy A M, Rich T A, Skibber J M. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma.  Ann Surg . 1996;  223 177-185
    CrossrefPubMedGoogle Scholar
  • 52 Alektiar K M, Zelefsky M J, Paty P B. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.  Int J Radiat Oncol Biol Phys . 2000;  48 219-226
    PubMedGoogle Scholar
  • 53 Gunderson L L, Nelson H, Martenson J A. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer.  Dis Colon Rectum . 1996;  39 1379-1395
    PubMedGoogle Scholar
  • 54 Rodel C, Grabenbauer G G, Matzel K E. Extensive surgery after high-dose chemoradiotherapy for locally advanced recurrent rectal cancer.  Dis Colon Rectum . 2000;  43 312-319
    PubMedGoogle Scholar
  • 55 Shaw E G, Gunderson L L, Martin J K. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis.  Radiother Oncol . 1990;  18 247-255
    CrossrefPubMedGoogle Scholar
  • 56 Nakfoor B M, Willet C G, Shellito P C. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on outcome of patients with locally advanced primary rectal and rectosigmoid cancer.  Ann Surg . 1998;  228 194-200
    CrossrefPubMedGoogle Scholar
  • 57 Magrini S, Nelson H, Gunderson L L, Sim F H. Sacropelvic resection and intraoperative electron irradiation in the management of recurrent anorectal cancer.  Dis Colon Rectum . 1996;  39 1-9
    PubMedGoogle Scholar
  • 58 Noyes R D, Weiss S M, Krall J M. Surgical complications of intraoperative radiation therapy; the Radiation Therapy Oncology Group Experience.  J Surg Oncol . 1992;  50 209-215
    PubMedGoogle Scholar
  • 59 Dobrowsky W, Schmid A P. Radiotherapy of presacral recurrence following radical surgery for rectal carcinoma.  Dis Colon Rectum . 1985;  28 917-919
    PubMedGoogle Scholar
  • 60 Pacini P, Cionin L, Pirtoll L. Symptomatic recurrence of carcinoma of the rectum and sigmoid: the influence of radiotherapy on the quality of life.  Dis Colon Rectum . 1986;  29 685-688
    PubMedGoogle Scholar
  • 61 Lingareddy V, Ahmad N R, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer.  Int J Radiat Oncol Biol Phys . 1997;  38 785-790
    CrossrefPubMedGoogle Scholar
  • 62 Goes R N, Beart Jr W R, Simons A J. Use of brachytherapy in management of locally recurrent rectal cancer.  Dis Colon Rectum . 1997;  40 1177-1179
    PubMedGoogle Scholar
  • 63 Meijer S, de Rooij D P, Derksen E J. Cryosurgery for locally recurrent rectal cancer.  Eur J Surg Oncol . 1992;  18 255-257
    PubMedGoogle Scholar
  • 64 Guadagni S, Fiorentini G, Palumbo G. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer.  Arch Surg . 2001;  136 105-112
    PubMedGoogle Scholar
  • 65 Vaglini M, Cascinelli F, Chiti A. Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer.  Tumori . 1996;  459-462
    PubMedGoogle Scholar
  • 66 Harris G J, Senagore A J, Lavery I C, Fazio V W. The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices.  Am J Surg . 2001;  181(6) 499-506
    CrossrefPubMedGoogle Scholar